Updated:
Nan Fung Life Sciences
Nan Fung Life Sciences is the life-sciences and sustainability investment arm of the Nan Fung Group, the Hong Kong conglomerate built by the late Chen Din...
Nan Fung Life Sciences
Nan Fung Life Sciences is the life-sciences and sustainability investment arm of the Nan Fung Group, the Hong Kong conglomerate built by the late Chen Din Hwa through textiles and real estate. It was established to deploy the family's capital into healthcare, biotechnology, and environmental innovation, with a global footprint. The firm invests across venture, growth, and private equity stages, targeting digital health, AI/ML in drug discovery, climate tech, and agri-tech. Portfolio holdings include companies such as Insilico Medicine (AI-driven drug discovery), C2Sense (chemical sensing for food quality), and Precision NanoSystems (RNA-based therapeutics), per public records. Geographically, the firm backs companies in North America, Europe, and Asia. Nan Fung Life Sciences maintains offices in San Francisco, Hellerup (Denmark), Chicago, Zug (Switzerland), and Palo Alto, reflecting a distributed team structure. The firm also operates a philanthropic foundation, the Nan Fung Life Sciences Foundation, which supports translational research and public health initiatives (per the firm's official communications). Recent activity includes participation in financing rounds for portfolio companies in the digital health and sustainability sectors. The firm's structural differentiator is its integration with the Nan Fung Group's broader real estate and operating-company assets, which provide co-investment and operational support for portfolio companies. It operates with a long-term, patient-capital mandate typical of single-family offices, focusing on themes aligned with the Chen family's legacy.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Hellerup, Denmark · Chicago, IL · Zug, Switzerland · Palo Alto, CA
Sector focus
Frequently asked questions
Who runs investment decisions at Nan Fung Life Sciences?
Investment decisions are led by a team of professionals with backgrounds in life sciences, venture capital, and private equity. The specific managing principals are not widely publicized, but the firm operates with a collaborative global team structure (public record).
What investment stages does Nan Fung Life Sciences typically target?
The firm invests across venture, growth, and private equity stages, focusing on life sciences, digital health, and sustainability companies. It participates in both early-stage and growth-stage rounds, per public records.
How is Nan Fung Life Sciences related to the Nan Fung Group?
Nan Fung Life Sciences is the dedicated life-sciences and sustainability investment arm of Nan Fung Group, the Hong Kong conglomerate founded by the late Chen Din Hwa. It operates as a single-family office leveraging the group's capital and assets.
What sectors does Nan Fung Life Sciences focus on?
The firm targets life sciences, digital health, AI/ML in drug discovery, climate tech, agri-tech, and sustainable innovations. It avoids pure-play consumer or real estate investments, consistent with its thematic mandate (public record).
Does Nan Fung Life Sciences maintain philanthropic structures?
Yes, the firm operates the Nan Fung Life Sciences Foundation, which supports translational research and public health initiatives, separate from its for-profit investment activities (per the firm's official communications).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: